Dr Reddy’s Generics Sugammadex Receives Tentative Approval in US
18 Mar 2026 //
FDA
Aspiro’s Generics Micafungin Na Receives Approval in US
17 Mar 2026 //
FDA
Glaxosmithkline’s Lynavoy Receives Approval in US
17 Mar 2026 //
FDA
Janssen’s Icotyde Receives Approval in US
17 Mar 2026 //
FDA
Formosa’s Generics Eribulin Mesylate Receives Approval in US
16 Mar 2026 //
FDA
App’s Generics Acamprosate Calcium Receives Approval in US
16 Mar 2026 //
FDA
Glenmark`s Generics Fluticasone Receives Approval in US
16 Mar 2026 //
FDA
Aurobindo Pharma’s Generics Citalopram Receives Approval in US
13 Mar 2026 //
FDA
Orbicular’s Generics Phytonadione Receives Approval in US
13 Mar 2026 //
FDA
Caplin’s Generics Potassium Phosphates Receives Approval in US
12 Mar 2026 //
FDA
Hetero’s Generics Promethazine HCl Receives Approval in US
12 Mar 2026 //
FDA
Gland’s Generics Brimonidine Tartrate Receives Approval in US
11 Mar 2026 //
FDA
Biocon’s Generics Liraglutide Receives Approval in US
11 Mar 2026 //
FDA
Zydus’ Generics Cevimeline HCl Receives Approval in US
11 Mar 2026 //
FDA
Humanwell’s Generics Desvenlafaxine Receives Approval in US
10 Mar 2026 //
FDA
Difgen Pharms’ Generics Mesalamine Receives Approval in US
10 Mar 2026 //
FDA
Apotex’s Generics Sitagliptin Receives Tentative Approval in US
10 Mar 2026 //
FDA
Strides’s Generics Milnacipran Receives Tentative Approval in US
09 Mar 2026 //
FDA
Steranco’s Generics Oxcarbazepine Receives Approval in US
09 Mar 2026 //
FDA
Contract Pharmacal’s Generics Famotidine Receives Approval in US
09 Mar 2026 //
FDA
Knack’s Generics Dexmedetomidine HCl Receives Approval in US
09 Mar 2026 //
FDA
Micro’s Generics Bisoprolol Fumarate Receives Approval in US
09 Mar 2026 //
FDA
E5 Pharma’s Generics Ivermectin Receives Approval in US
09 Mar 2026 //
FDA
Aphelion’s Pylarify Truvu Receives Approval in US
06 Mar 2026 //
FDA
Specgx’s Generics Tofacitinib Receives Tentative Approval in US
06 Mar 2026 //
FDA
Prinston’s Generics Gabapentin Receives Approval in US
06 Mar 2026 //
FDA
Aurobindo Pharma’s Generics Siponimod Receives Approval in US
06 Mar 2026 //
FDA
Anthea Pharma’s Generics Olanzapine Receives Approval in US
05 Mar 2026 //
FDA
Rubin Research’s Generics Ibuprofen Receives Approval in US
05 Mar 2026 //
FDA
Annora Pharma’s Generics Paroxetine HCl Receives Approval in US
05 Mar 2026 //
FDA
Micro’s Generics Cholestyramine Receives Approval in US
05 Mar 2026 //
FDA
Mylan’s Generics Aprepitant Receives Approval in US
05 Mar 2026 //
FDA
Puracap’s Generics Nintedanib Receives Tentative Approval in US
05 Mar 2026 //
FDA
Laurus’s Generics Emtricitabine Receives Approval in US
04 Mar 2026 //
FDA
Aspiro’s Generics Rocuronium Bromide Receives Approval in US
04 Mar 2026 //
FDA
Graviti Pharms’ Generics Glipizide Receives Approval in US
04 Mar 2026 //
FDA
Zydus’ Generics Calcitonin-Salmon Receives Approval in US
04 Mar 2026 //
FDA
Glenmark’s Generics Fluticasone Propionate Receive Approval in US
03 Mar 2026 //
FDA
Gland’s Generics Brimonidine Receives Tentative Approval in US
02 Mar 2026 //
FDA
Epic Pharma’s Generics Oxcarbazepine Receives Approval in US
02 Mar 2026 //
FDA
Apotex’s Generics Rivaroxaban Receives Approval in US
02 Mar 2026 //
FDA
Taro’s Generics Efinaconazole Receives Tentative Approval in US
02 Mar 2026 //
FDA
Macleods’ Generics Moxifloxacin HCl Receives Approval in US
02 Mar 2026 //
FDA
Shandong New Time’s Generics Brivaracetam Receives Approval in US
26 Feb 2026 //
FDA
Zydus’ Generics Ivermectin Receives Approval in US
26 Feb 2026 //
FDA
Ajanta Pharma’s Generics Empagliflozin Receives Approval in US
25 Feb 2026 //
FDA
Rubin Research’s Generics Cetirizine HCl Receives Approval in US
25 Feb 2026 //
FDA
App’s Generics Hydrocortisone Receives Approval in US
25 Feb 2026 //
FDA
Dr Reddy’s Generics Dexmedetomidine HCl Receives Approval in US
25 Feb 2026 //
FDA
Eton Pharma’s Desmoda Receives Approval in US
25 Feb 2026 //
FDA
Eugia Pharma’s Generics Everolimus Receives Approval in US
25 Feb 2026 //
FDA
Natco’s Generics Alectinib Receives Approval in US
25 Feb 2026 //
FDA
Cipla’s Generics Palbociclib Receives Approval in US
25 Feb 2026 //
FDA
Amneal Ireland’s Generics Macitentan Receives Approval in US
25 Feb 2026 //
FDA
App Pharma’s Generics Sodium Sulfate Receives Approval in US
24 Feb 2026 //
FDA
Aurobindo Pharma’s Generics Sitagliptin Receives Approval in US
24 Feb 2026 //
FDA
AQ USA Inc’s Receives FDA Warning Letter
24 Feb 2026 //
FDA
MedisourceRx’s Receives FDA Warning Letter
24 Feb 2026 //
FDA
Yichang Humanwell’s Generics Micafungin Receives Approval in US
24 Feb 2026 //
FDA
Orbicular’s Generics Liraglutide Receives Approval in US
24 Feb 2026 //
FDA

Market Place
Sourcing Support